Pharmaceutical firm reaches deal with for new facility, set to start vaccine production in 2024...
Socio-Economic Developments
UK COVID Cases Rise As New Variant Discovered
Record 4.9M tested positive in week up to March 26; tour agencies warn of travel disruption during...
Latin American Countries Report Latest COVID-19 Situation
Brazil, Mexico, Colombia, Chile register more COVID-19 cases, deaths BOGOTA, Colombia Countries...
A Key Detail in Some People’s Childhoods May Lead to...
Most people welcomed the opportunity to get vaccinated against COVID-19, yet a non-trivial minority...
Shanghai Extends Covid-19 Lockdown As Omicron Cases Soar
Shanghai’s lockdown was due to end in four days but it has since been extended due to the speed of...
The BA.2 Subvariant is Now 72 Percent of New Covid Cases...
Although the subvariant has overtaken BA.1 in the U.S., cases still remain low nationally. The BA.2...
A Second Version Of Omicron Is Spreading. Here’s Why...
Just as the omicron surge starts to recede in parts of the U.S., scientists have their eye on...
Omicron Surge: Should We Shorten Self-isolation Time?
Omicron’s arrival has once again changed the course of the pandemic. The increased transmissibility...
FYI, Rapid Antigen Tests May Give More False Negatives With...
Rapid COVID home tests are more likely to give a false negative with the heavily-mutated Omicron...
Swab Your Throat First? Rapid Tests May Need Saliva to Detect...
Rapid COVID-19 tests that use nose swabs alone might not pick up Omicron in the early days of...
Life
Moderna to Produce 100M COVID Vaccine Doses Per Year in Australia
Pharmaceutical firm reaches deal with for new facility, set to start vaccine production in 2024...
Vaccination
A Key Detail in Some People’s Childhoods May Lead to...
Most people welcomed the opportunity to get vaccinated against COVID-19, yet a non-trivial minority...
Pharma
EXCLUSIVE Pardes To Go Public, Says COVID-19 Antiviral Pill Does...
Dec 21 (Reuters) – Pardes Biosciences on Tuesday said early human testing shows that its...
